Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells $974,073.28 in Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 21,536 shares of Phibro Animal Health stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $45.23, for a total transaction of $974,073.28. Following the completion of the sale, the chief executive officer owned 14,041 shares of the company’s stock, valued at $635,074.43. This trade represents a 60.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Jack Bendheim also recently made the following trade(s):

• On Thursday, November 13th, Jack Bendheim sold 8,801 shares of Phibro Animal Health stock. The stock was sold at an average price of $44.47, for a total value of $391,380.47.
• On Monday, November 10th, Jack Bendheim sold 38,303 shares of Phibro Animal Health stock. The stock was sold at an average price of $45.29, for a total value of $1,734,742.87.
• On Friday, November 7th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $42.86, for a total value of $150,867.20.
• On Tuesday, November 4th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $43.10, for a total value of $151,712.00.
• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.07, for a total value of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.56, for a total value of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total transaction of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.27, for a total transaction of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.38, for a total transaction of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.03, for a total transaction of $28,021.00.

Phibro Animal Health Price Performance

Phibro Animal Health stock opened at $45.10 on Friday. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $46.42. The firm has a market cap of $1.83 billion, a PE ratio of 38.22, a price-to-earnings-growth ratio of 1.24 and a beta of 0.81. The company’s 50 day moving average is $40.43 and its two-hundred day moving average is $31.89.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 earnings per share for the quarter, topping analysts’ consensus estimates of $0.58 by $0.15. The business had revenue of $363.89 million for the quarter, compared to analyst estimates of $345.44 million. Phibro Animal Health had a return on equity of 32.14% and a net margin of 3.73%. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, research analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Stockholders of record on Wednesday, November 26th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio (DPR) is presently 28.92%.

Wall Street Analyst Weigh In

PAHC has been the subject of a number of analyst reports. Weiss Ratings reissued a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Tuesday. Morgan Stanley set a $34.00 price target on shares of Phibro Animal Health in a research note on Thursday, August 28th. Zacks Research downgraded shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. raised their price objective on shares of Phibro Animal Health from $45.00 to $50.00 and gave the company an “overweight” rating in a report on Friday, November 7th. Finally, Bank of America lifted their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research report on Friday, August 29th. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $31.40.

Institutional Trading of Phibro Animal Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. National Bank of Canada FI acquired a new position in shares of Phibro Animal Health in the 1st quarter valued at $30,000. Financial Management Professionals Inc. acquired a new stake in Phibro Animal Health during the 2nd quarter worth $32,000. iSAM Funds UK Ltd acquired a new stake in Phibro Animal Health during the 3rd quarter worth $61,000. EverSource Wealth Advisors LLC lifted its position in Phibro Animal Health by 7,671.4% in the second quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock valued at $69,000 after acquiring an additional 2,685 shares during the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in Phibro Animal Health by 768.2% in the second quarter. Tower Research Capital LLC TRC now owns 4,610 shares of the company’s stock valued at $118,000 after acquiring an additional 4,079 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.